ab85137 staining S100
in a human melanoma cell line by Flow Cytometry.
After exploiting a technology that allowed them to activate each of nearly 16,000 genes individually
in human melanoma cell lines containing mutant BRAF, the authors then treated the panel of cells with the drugs and monitored which cells showed altered drug sensitivity.
Not exact matches
Beyond lung cancer, TiY is able to target TICs
in 28 types of
human cell lines derived from the central nervous system,
melanoma, breast, renal, ovarian, colon, and prostate cancer.
In one experiment this year, a team led by another CRISPR pioneer, Feng Zhang of the Broad Institute in Cambridge, Massachusetts, targeted the 20,000 or so known human genes, turning them on one by one in groups of cells to identify those involved in resistance to a melanoma dru
In one experiment this year, a team led by another CRISPR pioneer, Feng Zhang of the Broad Institute
in Cambridge, Massachusetts, targeted the 20,000 or so known human genes, turning them on one by one in groups of cells to identify those involved in resistance to a melanoma dru
in Cambridge, Massachusetts, targeted the 20,000 or so known
human genes, turning them on one by one
in groups of cells to identify those involved in resistance to a melanoma dru
in groups of
cells to identify those involved
in resistance to a melanoma dru
in resistance to a
melanoma drug.
One of these, UJ3, is as effective as the industry - standard drug Cisplatin
in killing cancer
cells in laboratory tests done on
human esophageal cancer, breast cancer and
melanoma.
In one published study, where we put
melanoma cells into mice, we published it with mouse
melanoma cells, but we repeated it with
human cells.
The Ogretmen laboratory screened previously reported microarray data sets of several
human tumor tissues (metastatic head and neck squamous
cell carcinoma,
melanoma, and renal
cell carcinoma) and showed that,
in these samples, only the levels of CerS4 were significantly decreased.
The research team analyzed BRAF inhibitor resistance
in melanoma cell lines, mice bearing
human melanoma tumors, and
in human tumor biopsy samples.
«What's cool about this group of genes is that they also get turned on
in human melanoma,» says Zon, who is also a member of the Harvard Stem
Cell Institute and a Howard Hughes Medical Institute investigator.
As a result, the researchers were able to prevent the growth and malignant spread of the cancer
in the animal model and
human melanoma cells.
Their preliminary findings indicate that MUS81 - induced movement of DNA to the cytosol also occurs
in human cancer
cells, including prostate cancer, breast cancer, colorectal cancer, uterine cancer, leukemia, and
melanoma cells.
While past attempts to treat
melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on
human cells in a petri dish takes a positive step toward creating a drug that can kill
melanoma cancer
cells without harming nearby healthy
cells.
In the study, the compound caused human melanoma cells to die and inhibited tumor growth by about 69 percent in a mouse mode
In the study, the compound caused
human melanoma cells to die and inhibited tumor growth by about 69 percent
in a mouse mode
in a mouse model.
The analysis also found that a significant fraction of tumors contained rearrangements and mutations of a gene called PREX2, and experiments confirmed that cancer - associated mutations of PREX2 promoted the growth of
human melanoma cells in mice.
Mukherji B, Chakraborty NG, Yamasaki S, Okino T, Yamase H, Sporn JR, Kurtzman SK, Ergin MT, Ozols J, Meehan J, Mauri F. Induction of antigen - specific cytolytic T
cells in situ
in human melanoma by immunization with synthetic peptide - pulsed autologous antigen presenting
cells.
Further research uncovered a broad spectrum of
cell surface stem
cell markers (e.g., CD133, CD44, and CD24) that allow the identification of CSCs
in human solid tumors, including brain, breast, prostate, pancreas, liver, ovary, skin, colon cancers, and
melanoma (3 - 6)(Figure 1 based on 7).
A dominant negative Cx43 mutant differentially affects tumorigenic and invasive properties
in human metastatic
melanoma cells.
Expression of the
melanoma cell adhesion molecule
in human mesenchymal stromal
cells regulates proliferation, differentiation, and maintenance of hematopoietic stem and progenitor
cells.
Intracellular retention of the NKG2D ligand MHC class I chain - related gene A
in human melanomas confers immune privilege and prevents NK
cell - mediated cytotoxicity.
They went on to show that Sox10, a factor needed for the formation of skin pigment
cells from neural crest stem
cells during development, was present at high levels
in naevi and
melanoma samples obtained from both the mouse model and
human patients.
Knocking out or blocking the activity of Nrp1 on regulatory T
cells in mouse models of several
human cancers, including the deadly skin cancer
melanoma, led to reduced, delayed or complete elimination of the tumors.
T - VEC, recently approved for the treatment of advanced
melanoma, is an oncolytic herpes simplex virus type 1 engineered to replicate selectively
in tumor
cells and express
human granulocyte - macrophage colony - stimulating factor.